Latest market price
21.82
-0.18-0.82%
TA
Loading chart...
Snapshot
| Index | — | P/E | — | EPS (ttm) | -0.87 | Insider Own | 2.60% | Shs Outstand | 112.84M | Perf Week | 4.56% |
| Market Cap | 2.48B | Forward P/E | — | EPS next Y | -0.22 | Insider Trans | 2.05% | Shs Float | 109.91M | Perf Month | 15.36% |
| Enterprise Value | 4.61B | PEG | — | EPS next Q | -0.22 | Short Float | 18.17% | Perf Quarter | 15.00% | ||
| Income | -68.00M | P/S | 1.65 | EPS this Y | — | Short Ratio | 9.26 | Perf Half Y | 58.39% | ||
| Sales | 1.50B | P/B | 1.02 | EPS next Y | — | ROA | -1.32% | Short Interest | 19.97M | Perf YTD | 94.35% |
| Book/sh | 21.48 | P/C | 8.62 | EPS next 5Y | — | ROE | -2.84% | 52W High | 22.14 -1.47% | Perf Year | 105.99% |
| Cash/sh | 2.55 | P/FCF | 11.28 | EPS past 3/5Y | — | ROIC | 1.07% | 52W Low | 9.99 118.37% | Perf 3Y | 69.49% |
| Dividend Est. | 0.04 (0.18%) | EV/EBITDA | 18.02 | Sales past 3/5Y | 1.97% 27.21% | Gross Margin | 18.61% | Volatility | 2.40% 3.40% | Perf 5Y | -0.59% |
| Dividend TTM | 0.04 (0.18%) | EV/Sales | 3.06 | EPS Y/Y TTM | — | Oper. Margin | 3.44% | ATR (14) | 0.64 | Perf 10Y | -16.54% |
| Dividend Ex-Date | Sep 30, 2026 | Quick Ratio | 1.21 | Sales Y/Y TTM | 2.73% | Profit Margin | -4.55% | RSI (14) | 73.59 | Recom | 2.82 |
| Dividend Gr. 3/5Y | 0.00% 0.00% | Current Ratio | 1.21 | EPS Q/Q | -51.35% | SMA20 | 8.73% | Beta | 1.43 | Target Price | 18.85 |
| Payout | — | Debt/Eq | 1.00 | Sales Q/Q | 1.00% | SMA50 | 15.47% | Rel Volume | 1.69 | Prev Close | 22.00 |
| Employees | 52 | LT Debt/Eq | 1.00 | Earnings | Feb 24 | SMA200 | 36.34% | Avg Volume | 2.32M | Price | 21.82 |
| IPO Date | Dec 09, 2009 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -2253.85% 2.34% | Net Debt/EBITDA | 8.32 | Volume | 3,909,975 | Change | -0.82% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-26-26 | Reiterated | Evercore ISI Group | In Line | $15 → $21 |
| Oct-22-26 | Reiterated | Morgan Stanley | Underweight | $14 → $15 |
| Oct-19-26 | Reiterated | Stifel Nicolaus | Buy | $21 → $22 |
| Oct-12-26 | Reiterated | Morgan Stanley | Underweight | $12 → $14 |
| Sep-28-26 | Reiterated | Raymond James | Outperform | $18 → $20 |
| Aug-27-26 | Reiterated | Barclays | Underweight | $15 → $14 |
| Aug-11-26 | Reiterated | Cantor Fitzgerald | Neutral | $15 → $19 |
| Jul-31-26 | Upgrade | Compass Point | Sell → Neutral | $15 → $20 |
| Jul-23-26 | Reiterated | Wells Fargo | Equal Weight | $20 → $19 |
| Jul-21-26 | Reiterated | Barclays | Underweight | $13 → $15 |
Latest News· Times ET
Oct-31-26
Oct-30-26
02:38PM
Pebblebrook Hotel Trust (PEB) Q3 2026 Earnings Call Transcriptseekingalpha.com
07:00AM
Oct-29-26
Oct-29-2608:30PM
08:06PM
07:13PM
04:06PM
Pebblebrook Hotel Trust Reports Third Quarter 2026 Resultsbusinesswire.com
Oct-27-26
Oct-21-26
08:01AM
06:31AM
Oct-20-26
Oct-20-2606:17PM
12:40PM
Company
Pebblebrook Hotel Trust, identified by its NYSE ticker PEB, operates as a publicly listed real estate investment trust (REIT) and stands as the foremost proprietor of urban and resort lifestyle hotels throughout the United States. Its substantial portfolio encompasses 53 properties, collectively offering approximately 13,200 guestrooms, situated across 14 distinct urban and resort destinations, with a particular emphasis on key West Coast metropolitan areas.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,505 | 1,476 | 1,453 | 1,420 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 1,225 | 1,574 | 1,087 | 1,066 | — | — | — | — | — | |
| Gross Profit | 280 | -99 | 366 | 354 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 48 | 49 | 48 | 45 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 180 | -223 | 234 | 271 | — | — | — | — | — | |
| Operating Income | 51 | 75 | 84 | 38 | — | — | — | — | — | |
| Interest Expense | 101 | 103 | 102 | 108 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -6 | -28 | -7 | -4 | — | — | — | — | — | |
| Net Income Before Taxes | -54 | -56 | -26 | -74 | — | — | — | — | — | |
| Income Taxes | 10 | 6 | -26 | 1 | — | — | — | — | — | |
| Consolidated Net Income | -68 | -66 | -4 | -78 | — | — | — | — | — | |
| Net Income From Continuing Operations | -65 | -62 | 0 | -74 | — | — | — | — | — | |
| Net Income | -68 | -66 | -4 | -78 | — | — | — | — | — | |
| EPS (Recurring) | -0.86 | -0.90 | -0.39 | -0.93 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -0.86 | -0.90 | -0.39 | -0.93 | — | — | — | — | — | |
| EPS (Diluted) | -0.87 | -0.90 | -0.39 | -0.93 | — | — | — | — | — | |
| EBITDA | 256 | 275 | 306 | 275 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 1.62 | 0.90 | 1.12 | 1.37 | — | — | — | — | — | |
| Gross Margin | 18.60 | -6.71 | 25.19 | 24.93 | — | — | — | — | — | |
| Operating Margin | 3.39 | 5.08 | 5.78 | 2.68 | — | — | — | — | — | |
| Net Margin | -4.52 | -4.47 | -0.28 | -5.49 | — | — | — | — | — | |
| Shares Outstanding | 112 | 117 | 120 | 122 | — | — | — | — | — | |
| Market Capitalization | 2,443 | 1,324 | 1,626 | 1,950 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Fisher Thomas Charles | Co-President, C Investmt Ofcr | Aug 03 '26 | Sale | 19.25 | 40,000 | 770,120 | 285,163 | Aug 04 |
| BORTZ JON E | Chairman and CEO | Jun 12 '26 | Buy | 18.18 | 20,000 | 363,600 | 1,657,110 | Jun 15 |
| BORTZ JON E | Chairman and CEO | Jun 11 '26 | Buy | 17.73 | 20,000 | 354,600 | 1,637,110 | Jun 12 |
| BORTZ JON E | Chairman and CEO | Jun 10 '26 | Buy | 17.23 | 20,000 | 344,600 | 1,617,110 | Jun 12 |
| BORTZ JON E | Chairman and CEO | Jun 09 '26 | Buy | 17.09 | 20,000 | 341,800 | 1,597,110 | Jun 09 |
| BORTZ JON E | Chairman and CEO | Jun 08 '26 | Buy | 16.84 | 20,000 | 336,800 | 1,577,110 | Jun 09 |
| BORTZ JON E | Chairman and CEO | Dec 15 '25 | Sale | 11.26 | 50,000 | 563,150 | 1,557,110 | Dec 16 |
| SCHALL MICHAEL J | Director | Nov 19 '25 | Buy | 10.85 | 10,000 | 108,500 | 119,693 | Nov 20 |
| SCHALL MICHAEL J | Director | Aug 19 '25 | Buy | 10.08 | 10,000 | 100,800 | 109,693 | Aug 21 |
| BORTZ JON E | Chairman and CEO | Jun 06 '25 | Buy | 9.50 | 5,000 | 47,500 | 1,607,110 | Jun 06 |
| BORTZ JON E | Chairman and CEO | May 30 '25 | Buy | 9.15 | 18,000 | 164,700 | 1,602,110 | May 30 |
| BORTZ JON E | Chairman and CEO | May 27 '25 | Buy | 9.00 | 6,000 | 54,000 | 1,584,110 | May 28 |
| Jackson Ron E. | Director | May 23 '25 | Buy | 8.91 | 10,000 | 89,100 | 106,898 | May 23 |
| BORTZ JON E | Chairman and CEO | May 22 '25 | Buy | 8.99 | 20,000 | 179,800 | 1,578,110 | May 23 |
| BORTZ JON E | Chairman and CEO | May 20 '25 | Buy | 9.73 | 23,213 | 225,862 | 1,558,110 | May 21 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.